Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach-Reference-Cited by-同舟云学术

Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach

Published:2022-03-26 Issue:3 Volume:14 Page:139-151
ISSN:1949-8462
Container-title:World Journal of Cardiology
language:
Short-container-title:WJC

Author:

Arsenos Petros,Gatzoulis Konstantinos A,Tsiachris Dimitrios,Dilaveris Polychronis,Sideris Skevos,Sotiropoulos Ilias,Archontakis Stefanos,Antoniou Christos-Konstantinos,Kordalis Athanasios,Skiadas Ioannis,Toutouzas Konstantinos,Vlachopoulos Charalambos,Tousoulis Dimitrios,Tsioufis Konstantinos

Publisher

Baishideng Publishing Group Inc.

Subject

Cardiology and Cardiovascular Medicine

Reference70 articles.

1. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

2. Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy

3. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

4. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases

5. Myocardial fibrosis predicts ventricular tachyarrhythmias

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy;Heart Failure Clinics;2024-10

2. Programmed ventricular stimulation for risk stratification in hypertrophic cardiomyopathy patients;European Heart Journal;2024-05-31

3. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy;Cardiology Clinics;2023-11

4. The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data;Biomedicines;2023-09-02

5. The Role of Genetics in Risk Stratification Strategy of Dilated Cardiomyopathy;Reviews in Cardiovascular Medicine;2022-09-09